5-MeO-2,N,N-TMT

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
5-MeO-2,N,N-TMT
File:5-MeO-2,N,N-TMT.svg
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H20N2O
Molar mass232.321 g/mol
3D model (JSmol)

5-MeO-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#45) [1]. It is claimed to show psychoactive effects at a dosage of 75-150mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.


References

Template:TiHKAL Template:Hallucinogenic tryptamines Template:Hallucinogen-stub

Template:WikiDoc Sources